Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,829 Lymphoma
clinical trials

Oncology Clinical Trial
Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
Status: Enrolling
Updated: 3/20/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
SCRI Tissue Testing Registry
Status: Enrolling
Updated: 1/31/2013
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Status: Enrolling, Phase II
Updated: 11/13/2015
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
Status: Enrolling, Phase I
Updated: 10/8/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Leukemia-Lymphoma, Adult T-Cell Clinical Trial
EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Status: Enrolling, Phase I, II
Updated: 10/7/2013
University of Miami Hospital/Sylvester
mi
from
Miami, FL
Click here to add this to my saved trials
Leukemia-Lymphoma, Adult T-Cell Clinical Trial
EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Status: Enrolling, Phase I, II
Updated: 10/7/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Status: Enrolling
Updated: 6/1/2012
Northwestern University Med School
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Status: Enrolling
Updated: 6/1/2012
Horizon Oncology Center
mi
from
Lafayette, IN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Status: Enrolling
Updated: 6/1/2012
Univ of California San Fransico Med Center
mi
from
San Fransisco, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
Baylor University Medical Center - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
Childrens National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
Status: Enrolling, Phase I
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Rice Memorial Hospital
mi
from
Willmar, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic - Wooster Family Health Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 11/3/2014
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 11/3/2014
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 11/3/2014
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 11/3/2014
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 11/3/2014
Texas Oncology Seton Williamson
mi
from
Round Rock, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 11/3/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cutaneous T-Cell Lymphoma Clinical Trial
Everolimus in Treating Cutaneous T-cell Lymphoma
Status: Enrolling, Phase II
Updated: 1/28/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Status: Enrolling, Phase
Updated: 12/31/1969
Louisiana State University Public Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3023414 in Participants With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3023414 in Participants With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Mantle-Cell Lymphoma Clinical Trial
Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/23/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Status: Enrolling
Updated: 12/13/2012
Texas Oncology
mi
from
Bedord, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Murray, UT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Skokie, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoma Clinical Trial
Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas
Status: Enrolling, Phase I, II
Updated: 1/24/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 1/7/2013
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 1/7/2013
Southwest General Health Center Ireland Cancer Center
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology Seton Williamson
mi
from
Round Rock, TX
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwest Cancer Specialists, PC
mi
from
Tualatin, OR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide After Allo Transplant
Status: Enrolling, Phase I
Updated: 12/13/2012
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Waldenstrom Macroglobulinemia Clinical Trial
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Status: Enrolling
Updated: 4/9/2013
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Waldenstrom Macroglobulinemia Clinical Trial
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Status: Enrolling
Updated: 4/9/2013
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
T-Lymphocytes in Treating Patients With Active or Relapsed Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Status: Enrolling
Updated: 3/15/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
T-Lymphocytes in Treating Patients With Active or Relapsed Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Status: Enrolling
Updated: 3/15/2012
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Status: Enrolling
Updated: 6/14/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Persistent or Recurrent Cutaneous T-Cell Lymphoma Clinical Trial
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Persistent or Recurrent Cutaneous T-Cell Lymphoma Clinical Trial
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of South Florida College of Medicine
mi
from
Tampa, FL
Click here to add this to my saved trials
Persistent or Recurrent Cutaneous T-Cell Lymphoma Clinical Trial
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
Status: Enrolling
Updated: 12/3/2015
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
T Cell Non-Hodgkin Lymphoma Clinical Trial
A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Lymphoma Clinical Trial
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
Status: Enrolling, Phase I
Updated: 11/22/2016
Memorial Sloan Ketttering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Multiple Ascending Dose Study of DS-3032b, an Oral Murine Double Minute 2 (MDM2) Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Multiple Ascending Dose Study of DS-3032b, an Oral Murine Double Minute 2 (MDM2) Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Multiple Ascending Dose Study of DS-3032b, an Oral Murine Double Minute 2 (MDM2) Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
Status: Enrolling, Phase I
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Status: Enrolling, Phase I, II
Updated: 4/29/2018
Columbus NCORP
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Status: Enrolling, Phase I, II
Updated: 4/29/2018
Geisinger Cancer Institute NCORP
mi
from
Danville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Status: Enrolling, Phase I, II
Updated: 4/29/2018
Kansas City NCORP
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Status: Enrolling, Phase I, II
Updated: 4/29/2018
Nevada NCORP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Status: Enrolling, Phase I, II
Updated: 4/29/2018
Gulf South MU-NCORP
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Status: Enrolling, Phase I, II
Updated: 4/29/2018
Pacific Cancer Research Consortium Ncorp
mi
from
Portland, OR
Click here to add this to my saved trials
Lymphoma Clinical Trial
Detection of Cardiac Fibrosis in Patients With Lymphoma
Status: Enrolling, Phase
Updated: 2/3/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth St. Joseph Medical Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Missouri Health Care
mi
from
Columbia, MO
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Veterans Affairs New Jersey Health Care System
mi
from
East Orange, NJ
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Medical Specialties PLLC
mi
from
Gig Harbor, WA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
C.R. Wood Cancer Center at Glens Falls Hospital
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology and Oncology Associates of SC, LLC
mi
from
Greenville, SC
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Whittingham Cancer Center
mi
from
Norwalk, CT
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Rex Cancer Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Rutland Regional Medical Center
mi
from
Rutland, VT
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Sansum Clinic
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Medical Research Institute
mi
from
Springfield, MO
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Texas Veterans Health Care System
mi
from
Temple, TX
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Tyler Hematology Oncology PA
mi
from
Tyler, TX
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology and Oncology
mi
from
Waterbury, CT
Click here to add this to my saved trials
Oncology Clinical Trial
ACY-1215 for Relapsed/Refractory Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 5/16/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
ACY-1215 for Relapsed/Refractory Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 5/16/2017
Moffit Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Status: Enrolling, Phase
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
1 … 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 … 98